Advanced search for publications
Enter your keywords
Lidocaine/prilocaine spray for premature ejaculation (update)
Lidocaine/prilocaine spray (Fortacin®) is a mixture of lidocaine and prilocaine licensed for the treatment of primary premature ejaculation (PE) in adult men.
Melatonin prolonged-release (Slenyto) for insomnia in neurodevelopmental disorders
Melatonin prolonged-release tablets (Slenyto, Flynn Pharma) are the first oral melatonin formulation to be approved for use in children. Slenyto is indicated for the treatment of insomnia in children and adolescents (2 to 18 years old) with autism spectrum disorder (ASD) and/or Smith-Magenis syndrome (SMS), where sleep hygiene measures have been insufficient.
Ertugliflozin for type 2 diabetes
Ertugliflozin is the fourth sodium glucose co-transporter-2 inhibitor to be licensed in the UK. It is indicated as an adjunct to diet and exercise control to improve glycaemic control in adults with type 2 diabetes.
Cariprazine for the treatment of schizophrenia in adults
Cariprazine (Reagila®) is a once-daily, oral, atypical antipsychotic for the treatment of schizophrenia in adults. Download the full review below to read more.
5-aminolevulinic acid patches for actinic keratosis
5-aminolevulinic acid patches (Alacare®, medac pharma) are licensed in combination with photodynamic therapy as a single dose treatment for up to 6 mild actinic keratosis lesions on hairless areas of the face and scalp. Download the full review below to read more.
Semaglutide for type 2 diabetes
Semaglutide (Ozempic®▼, Novo Nordisk) is a GLP1 receptor agonist (GLP1RA) indicated as an adjunct to diet and exercise for the treatment of adults with insufficiently controlled type 2 diabetes mellitus. Download the full review below to read more.
Fluticasone, umeclidinium, and vilanterol (Trelegy Ellipta) for COPD
Fluticasone furoate/umeclidinium bromide/vilanterol dry powder inhaler (Trelegy Ellipta®) is a fixed-dose triple combination of a corticosteroid (ICS), a long-acting anti-muscarinic (LAMA) and a long-acting beta-agonist (LABA) for relief of symptoms in adults with chronic obstructive pulmonary disease. This review is older than 3 years and has been archived. To request a copy, contact nuth.nyrdtc.rxsupp@nhs.net.